GermanOncology has developed Data4GO, a modular and completely web-based documentation software for the collection and evaluation of medical study data.
GermanOncology has developed web-based revenue and cost calculators based on reimbursement processes and fee systems for various tumour diseases.
We offer you license models for therapies in oncological, urological, haematological and psychiatric areas, among others, but we also offer new calculators, individually designed for your needs. Therapies under inpatient, day-care and outpatient conditions are modelled and represented graphically, taking regional conditions into account. You are free to choose the length of your access: The different license models are available for 12, 24 or 36 months.
The licenses include the online and offline use of the calculators, without additional installations
Flexible use from any Internet-enabled computer, tablet and smartphone (including iOS)
Optional consideration of personnel and material costs/infrastructure
Input option for individualised parameters (e.g. daily rates, quarterly flat rates and unweighted additional charges)
Options for regional parameters (e.g. 17 “KV” districts, country base case values, oncology agreements)
Revenue displays on, e.g. cycle, quarterly and average patient basis
Display by positive/negative bar charts with consideration of costs for personnel and infrastructure for quick overviews
Proceeds from medical services under various forms of outpatient care (including statutory health insurance physician, § 116b, authorised hospital doctors, a day clinic, university outpatient clinic).
Proceeds from drug supply for all current treatment regimens for one indication
Revenue from medical services and medication supply
Revenue from inpatient care with/without additional charges
Revenue from contractual medical services in 17 “KV” districts
Revenues from various chemotherapy applications (e.g. intravenous versus subcutaneous)
Comparison of revenues from different therapies under different care structures and specialist groups within one indication